U.S. Patient Engagement Solutions Market Size, Share, and Trends 2024 to 2034

The U.S. patient engagement solutions market size is calculated at USD 7.40 billion in 2025 and is forecasted to reach around USD 25.21 billion by 2034, accelerating at a CAGR of 14.68% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 5767
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Patient Engagement Solutions Market 

5.1. COVID-19 Landscape: U.S. Patient Engagement Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Patient Engagement Solutions Market, By Component

8.1. U.S. Patient Engagement Solutions Market, by Component

8.1.1. Software

8.1.1.1. Market Revenue and Forecast

8.1.2. Services

8.1.2.1. Market Revenue and Forecast

8.1.3. Hardware

8.1.3.1. Market Revenue and Forecast

Chapter 9. U.S. Patient Engagement Solutions Market, By Therapeutic Area

9.1. U.S. Patient Engagement Solutions Market, by Therapeutic Area

9.1.1. Chronic Diseases

9.1.1.1. Market Revenue and Forecast

9.1.2. FitnessDessert

9.1.2.1. Market Revenue and Forecast

9.1.3. Women’s Health

9.1.3.1. Market Revenue and Forecast

9.1.4. Mental Health

9.1.4.1. Market Revenue and Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Forecast

Chapter 10. U.S. Patient Engagement Solutions Market, By Functionality

10.1. U.S. Patient Engagement Solutions Market, by Functionality

10.1.1. Communication

10.1.1.1. Market Revenue and Forecast

10.1.2. Health Tracking and Insights

10.1.2.1. Market Revenue and Forecast

10.1.3. Billing and Payments

10.1.3.1. Market Revenue and Forecast

10.1.4. Administrative

10.1.4.1. Market Revenue and Forecast

10.1.5. Patient Education

10.1.5.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. U.S. Patient Engagement Solutions Market, By Application

11.1. U.S. Patient Engagement Solutions Market, by Application

11.1.1. Social Management

11.1.1.1. Market Revenue and Forecast

11.1.2. Health Management

11.1.2.1. Market Revenue and Forecast

11.1.3. Home Healthcare Management

11.1.3.1. Market Revenue and Forecast

11.1.4. Financial Health Management

11.1.4.1. Market Revenue and Forecast

Chapter 12. U.S. Patient Engagement Solutions Market, By End Use

12.1. U.S. Patient Engagement Solutions Market, by End Use

12.1.1PayersCheese

12.1.1.1. Market Revenue and Forecast

12.1.2. Providers

12.1.2.1. Market Revenue and Forecast

12.1.3. Individual Users

12.1.3.1. Market Revenue and Forecast

Chapter 13. U.S. Patient Engagement Solutions Market, By Delivery Type

13.1. U.S. Patient Engagement Solutions Market, by Delivery Type

13.1.1. Web/Cloud-based

13.1.1.1. Market Revenue and Forecast

13.1.2. On-premise

13.1.2.1. Market Revenue and Forecast

Chapter 14. U.S. Patient Engagement Solutions Market,Trend Forecast

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Component

14.1.7.2. Market Revenue and Forecast, by Therapeutic Area

14.1.7.3. Market Revenue and Forecast, by Functionality

14.1.7.4. Market Revenue and Forecast, by Application

14.1.8. Market Revenue and Forecast, by End Use

14.1.8.1. Market Revenue and Forecast, by Delivery Type  

Chapter 15. Company Profiles

15.1. Athenahealth

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Cerner Corporation (Oracle)

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. IBM

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Epic Systems Corporation

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Allscripts Healthcare, LLC

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6.McKesson Corporation

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. ResMed

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Nuance Communications, Inc.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Koninklijke Philips N.V.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Klara Technologies, Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The U.S. patient engagement solutions market size is expected to grow from USD 6.41 billion in 2024 to USD 25.21 billion by 2034.

The U.S. patient engagement solutions market is anticipated to grow at a CAGR of 14.68% between 2025 and 2034.

The major players operating in the U.S. patient engagement solutions market are Athenahealth, Cerner Corporation (Oracle), IBM, Epic Systems Corporation, Allscripts Healthcare, LLC, McKesson Corporation, ResMed, Nuance Communications, Inc., Koninklijke Philips N.V., Klara Technologies, Inc., CPSI, Ltd., and Others.

The driving factors of the U.S. patient engagement solutions market are the value-based care models has increased in the U.S., driving the market. Increased demand for personalized healthcare experiences and the adoption of telehealth further contribute to the market growth.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client